Efficacy of Recombinant Human Parathyroid Hormone 1–34 and Vitamin K2
Combination Therapy in Postmenopausal Osteoporosis
Zhuo Zhang,
Kun Xia,
Wentao Gong
et al.
Abstract:This study aimed to assess the efficacy and safety of a combined recombinant
human parathyroid hormone 1–34 [rhPTH (1–34)] and vitamin K2 therapy versus
vitamin K2 alone in the treatment of postmenopausal osteoporosis. A total of 77
postmenopausal osteoporosis patients were randomly divided into two groups.
Patients in one group received vitamin K2 alone, while patients in the other
group received a combination … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.